Taiko Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,256	4,532	5,484	3,105	5,796
Short-Term Investments	-	-	-	400	302
Cash & Short-Term Investments	4,256	4,532	5,484	3,505	6,098
Cash Growth	-6.09%	-17.36%	56.46%	-42.52%	23.34%
Accounts Receivable	2,449	2,428	1,985	1,798	4,056
Other Receivables	1	-	-	-	-
Receivables	2,450	2,428	1,985	1,798	4,056
Inventory	1,618	1,675	1,373	1,952	3,205
Other Current Assets	109	126	267	301	424
Total Current Assets	8,433	8,761	9,109	7,556	13,783
Property, Plant & Equipment	3,312	3,271	3,581	6,397	7,113
Long-Term Investments	268	747	526	867	1,338
Other Intangible Assets	34	27	1	222	299
Long-Term Deferred Tax Assets	221	105	1	2	-
Other Long-Term Assets	2	3	2	2	2
Total Assets	12,270	12,914	13,220	15,046	22,535
Accounts Payable	936	338	375	274	309
Accrued Expenses	247	176	75	23	149
Current Portion of Long-Term Debt	792	1,206	1,206	1,039	923
Current Portion of Leases	14	18	27	29	36
Current Income Taxes Payable	15	728	782	571	1,282
Other Current Liabilities	505	389	581	857	1,621
Total Current Liabilities	2,509	2,855	3,046	2,793	4,320
Long-Term Debt	-	792	1,999	2,720	3,760
Long-Term Leases	10	11	22	21	54
Pension & Post-Retirement Benefits	623	655	624	659	805
Long-Term Deferred Tax Liabilities	6	20	188	125	104
Other Long-Term Liabilities	604	618	603	685	686
Total Liabilities	3,752	4,951	6,482	7,003	9,729
Common Stock	10	10	2,267	1,201	1,201
Additional Paid-In Capital	4,978	4,997	2,689	1,642	1,648
Retained Earnings	3,450	2,526	1,628	5,239	10,134
Treasury Stock	-237	-273	-300	-348	-388
Comprehensive Income & Other	317	703	454	309	211
Shareholders' Equity	8,518	7,963	6,738	8,043	12,806
Total Liabilities & Equity	12,270	12,914	13,220	15,046	22,535
Total Debt	816	2,027	3,254	3,809	4,773
Net Cash (Debt)	3,440	2,505	2,230	-304	1,325
Net Cash Growth	37.33%	12.33%	-	-	-72.68%
Net Cash Per Share	68.48	49.92	47.09	-6.97	30.45
Filing Date Shares Outstanding	50.25	50.19	50.15	43.58	43.58
Total Common Shares Outstanding	50.25	50.19	49.95	43.58	43.58
Working Capital	5,924	5,906	6,063	4,763	9,463
Book Value Per Share	169.51	158.65	134.90	184.57	293.84
Tangible Book Value	8,484	7,936	6,737	7,821	12,507
Tangible Book Value Per Share	168.83	158.11	134.88	179.48	286.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.